Related Experiment Video
Updated: Feb 6, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion
Eiichi Sasaki1, Daisuke Nishikawa2, Nobuhiro Hanai2
1Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.
Aims:
Molecular targeted therapy against EGFR kinase domain mutations has been successfully established for lung cancer. These mutations have now also been reported in head and neck tumours, particularly in inverted sinonasal papillomas (ISPs). The aim of this study was to clarify the spectrum of EGFR mutations in head and neck squamous cell carcinomas and papillomas.
Methods And Results:
We examined EGFR mutations in 288 head and neck squamous cell carcinomas and 58 head and neck papillomas or polyps. EGFR mutations were detected in 24 (30%) of 80 sinonasal squamous cell carcinomas (SNSCCs) and in 19 (90%) of 21 ISPs. Notably, 15 (88%) of 17 SNSCCs that developed along with ISPs harboured EGFR mutations in both components, whereas EGFR mutations were detected in nine (14%) of 63 SNSCCs without any papilloma component. Analysis to detect other known driver oncogene mutations - KRAS, BRAF and HER2 - was also performed; none of these mutations was detected in SNSCCs. The other 208 non-sinonasal carcinomas and 37 non-ISP head and neck papillomas or polyps did not harbour EGFR mutations.
Conclusions:
Taken together with the specific involvement of EGFR mutations in ISP, a molecular benign lesion trail suggests that 26 (33%) of 80 SNSCCs developed in association with an ISP. SNSCCs with EGFR mutations may be biologically distinct among head and neck cancers.
Insights
Epidermal growth factor receptor (EGFR) mutations are common in inverted sinonasal papillomas (ISPs) and associated sinonasal squamous cell carcinomas (SNSCCs). These findings suggest a potential molecular link and distinct biological behavior for these head and neck cancers.
Area of Science:
- Oncology
- Molecular Biology
- Head and Neck Cancer Research
Background:
- Epidermal growth factor receptor (EGFR) targeted therapy is established for lung cancer.
- EGFR mutations have been identified in head and neck tumors, particularly inverted sinonasal papillomas (ISPs).
Purpose of the Study:
- To investigate the prevalence and spectrum of EGFR mutations in head and neck squamous cell carcinomas (HNSCCs) and papillomas.
- To explore the association between EGFR mutations in ISPs and co-occurring HNSCCs.
Main Methods:
- Analysis of EGFR mutations in 288 HNSCCs and 58 head and neck papillomas/polyps.
- Genomic analysis for KRAS, BRAF, and HER2 mutations in SNSCCs.
Main Results:
- EGFR mutations were found in 30% of sinonasal SCCs (SNSCCs) and 90% of ISPs.
- Notably, 88% of SNSCCs co-occurring with ISPs showed EGFR mutations in both tumor types.
- No KRAS, BRAF, or HER2 mutations were detected in SNSCCs.
Conclusions:
- EGFR mutations are prevalent in ISPs and associated SNSCCs, suggesting a potential precursor-malignancy relationship.
- EGFR-mutated SNSCCs may represent a distinct molecular subtype within head and neck cancers.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Cancers Originate from Somatic Mutations in a Single Cell
Mutations in Microorganisms

